By admin 
CureSearch for Children’s Cancer, a leading national non-profit organization dedicated to ending childhood cancer by driving targeted and innovative research, has officially announced the appointment of Mark Zafra to its Board of Directors. Zafra, a highly accomplished executive with over 20 years of experience in global supply chain management, procurement, and strategic sourcing, joins the board at a critical juncture for the organization. His appointment reflects a strategic effort by CureSearch to integrate high-level corporate expertise with its mission to overcome the systemic barriers that frequently stall the development of new pediatric cancer treatments. Currently serving as the Chief Procurement Officer at LiveRamp, Zafra brings a wealth of experience in operational transformation and fiscal stewardship, qualities that are increasingly vital in the non-profit sector where resource optimization directly correlates to the pace of scientific discovery.
The addition of Zafra to the board is not merely a professional alignment but a deeply personal one. As a cancer survivor celebrating 20 years since his initial diagnosis, Zafra represents the lived experience of the patients CureSearch strives to protect. His dual perspective as a seasoned corporate leader and a survivor provides the board with a unique vantage point on the urgency of medical innovation. His appointment comes as CureSearch continues to refine its "Catapult" funding model, which focuses on moving research out of the laboratory and into clinical trials—a phase of development often referred to as the "valley of death" due to the high costs and regulatory hurdles involved.
A Distinguished Career in Global Operations and Procurement
Mark Zafra’s professional trajectory is characterized by a consistent record of leading complex, large-scale transformations within some of the world’s most prominent technology and healthcare-adjacent firms. At LiveRamp, a leading data connectivity platform, Zafra oversees global strategic sourcing, purchasing, travel, and accounts payable. His role is central to the company’s operational efficiency, requiring a meticulous approach to vendor management and internal financial structures.
Before his tenure at LiveRamp, Zafra held influential leadership positions at Twitter, where he managed global sourcing and procurement during periods of significant organizational scaling. His resume also includes pivotal roles at Allianz Fireman’s Fund, HP, and Agilent Technologies. Notably, his experience at McKesson—a global leader in healthcare supply chain management solutions and retail pharmacy—provided him with direct insight into the complexities of the medical industry. This background is particularly relevant to CureSearch, as the organization navigates the intricate supply chains of pharmaceutical development and the logistical challenges of funding multi-site clinical trials.
Zafra’s expertise in procurement is expected to enhance CureSearch’s ability to manage its diverse portfolio of research grants and corporate partnerships. By applying rigorous business analytics and strategic sourcing principles to the non-profit model, Zafra will assist the organization in maximizing the impact of every dollar raised, ensuring that donor contributions are directed toward the most promising and efficient pathways to a cure.
Personal Resilience and the Twenty-Year Milestone
The motivation behind Zafra’s involvement with CureSearch is rooted in his personal history with the disease. This year marks the 20th anniversary of his first cancer diagnosis, a milestone that serves as a testament to the advancements in oncology over the past two decades. However, his survival also highlights the disparities between adult and pediatric cancer research. While adult oncology has seen a surge in personalized medicine and immunotherapy, pediatric treatments have historically lagged behind, often relying on decades-old protocols that can cause long-term health complications for children.
To commemorate his 20-year anniversary and to actively support the cause, Zafra is participating in the CureSearch Ultimate Hike in Jackson, Wyoming. This endurance event is a cornerstone of CureSearch’s community fundraising efforts, challenging participants to complete high-mileage treks in a single day to raise funds for cutting-edge research. Zafra’s participation in the hike underscores his commitment to the organization’s "boots on the ground" efforts, bridging the gap between board-level governance and grassroots activism.
"It is with great enthusiasm and a deep sense of responsibility that I join CureSearch’s Board of Directors," Zafra stated regarding his appointment. "As a survivor myself, I am a passionate advocate for advancing cancer research and am honored by the opportunity to contribute my skills and experience to a mission that matters deeply to me."
The Landscape of Pediatric Cancer Research and Funding
To understand the significance of Zafra’s appointment, it is necessary to examine the current state of pediatric oncology. Childhood cancer remains the leading cause of death by disease among children in the United States. Despite this, pediatric cancer research receives only a small fraction of the federal funding allocated to cancer research as a whole. According to data from the National Cancer Institute (NCI), only about 4% of the federal budget for cancer research is dedicated specifically to childhood cancers.
This funding gap creates a reliance on non-profit organizations like CureSearch to fill the void. CureSearch’s strategy focuses on three primary pillars:
- Accelerating Clinical Trials: Reducing the time it takes for new drugs to reach pediatric patients.
- Addressing High-Risk Cancers: Focusing on types of cancer that have low survival rates and few treatment options, such as certain brain tumors and sarcomas.
- Reducing Long-Term Toxicity: Developing treatments that are not only effective in killing cancer cells but also safer for the developing bodies of children, thereby reducing the "late effects" of treatment like heart disease and secondary cancers.
Zafra’s background in procurement and efficiency is particularly applicable to the first pillar. By streamlining the processes by which research is funded and monitored, CureSearch can help researchers navigate the regulatory landscape more effectively, potentially shaving years off the development timeline for new therapies.
Strategic Governance and Official Responses
The leadership at CureSearch has expressed significant confidence in Zafra’s ability to contribute to the organization’s strategic goals. Jared Brancazio, the CureSearch Board Chair, highlighted the synergy between Zafra’s professional skills and his personal dedication.
"Mark’s professional leadership and personal commitment to advancing cancer research make him an incredible addition to the CureSearch Board," Brancazio said. "We’re honored to have him help guide our work and accelerate our impact."
The Board of Directors at CureSearch is tasked with overseeing the organization’s financial health, strategic direction, and adherence to its mission. In an era where donors are increasingly demanding transparency and measurable results, having a Chief Procurement Officer on the board provides an extra layer of fiscal oversight. Zafra will likely play a role in evaluating the cost-effectiveness of various research initiatives and helping the organization scale its operations to meet the growing demand for pediatric oncology solutions.
Chronology of Mark Zafra’s Path to CureSearch
The timeline of Zafra’s career and his subsequent appointment to the board illustrates a logical progression toward high-impact philanthropy:
- Early 2000s: Zafra begins his career in procurement and supply chain, holding foundational roles at Agilent Technologies and HP, where he developed expertise in global sourcing.
- 2004: Zafra receives his first cancer diagnosis, beginning a personal journey through treatment and recovery that would eventually inform his advocacy work.
- 2010s: Zafra ascends to leadership roles at McKesson and Allianz Fireman’s Fund, gaining experience in the healthcare sector and risk management.
- 2017–2022: At Twitter, Zafra leads global sourcing initiatives, managing large-scale operations for one of the world’s most influential tech platforms.
- 2022–Present: Zafra joins LiveRamp as Chief Procurement Officer, further refining his expertise in corporate efficiency and strategic purchasing.
- 2024: Marking 20 years of cancer survivorship, Zafra is appointed to the CureSearch Board of Directors and commits to the Ultimate Hike in Jackson, WY.
Broader Implications for the Non-Profit Sector
Zafra’s appointment is indicative of a broader trend in the non-profit world: the "professionalization" of boards through the recruitment of tech and operations executives. As non-profits face increasingly complex global challenges, the need for expertise in data analytics, supply chain resilience, and strategic procurement has become paramount.
For CureSearch, Zafra’s presence on the board may signal a move toward more data-driven decision-making. In the context of medical research, this could involve utilizing procurement strategies to lower the costs of laboratory equipment for grantees or leveraging data connectivity insights from Zafra’s experience at LiveRamp to better understand donor demographics and research outcomes.
Furthermore, Zafra’s role as a survivor-leader helps to humanize the data. In the specialized field of pediatric oncology, where the "market" for new drugs is often considered too small by major pharmaceutical companies to justify investment, the advocacy of high-level executives can help shift the narrative. By demonstrating that pediatric cancer research is not just a moral imperative but a field that can benefit from rigorous business logic and operational excellence, Zafra and CureSearch are working to make the "business" of saving children’s lives more sustainable and effective.
As CureSearch prepares for its upcoming fiscal year and the Jackson, WY Ultimate Hike, the organization is positioned to leverage Zafra’s unique skillset to expand its reach. The ultimate goal remains clear: to ensure that every child diagnosed with cancer has access to safe, effective treatment options and the opportunity to lead a long, healthy life—a goal that Mark Zafra, through his 20-year survival and his professional dedication, embodies.
